Apicore US LLC.

Please contact us by phone or email to discuss new business opportunities.

Product Search : FDP Form:   And/Or   Name/Keyword:
View all Products
Dimethyl Fumarate
Product FDP Form: Solid Oral
FDP Presentation: Capsule
Apicore API Status: R & D
Apicore API Market Status: Dev Qtys
DMF Status: R&D
Therapeautic category: Immunomodulator
Dosage Form: Capsule
Route: oral
RLD: TECFIDERA
Strengths: 120 mg or 240 mg
Indication: The treatment of patients with relapsing forms of multiple sclerosis.
Go To Products